Navigation Links
Innovation for Personalised Cancer Treatment With DEPICT and Wolfmet 3D Tungsten by M&I Materials
Date:7/5/2017

MANCHESTER, England, July 5, 2017 /PRNewswire/ -- Wolfmet 3D printed tungsten collimator manufactured by M&I Materials proves to be the perfect answer as physics and manufacturing combine to progress molecular radiotherapy imaging.

In molecular radiotherapy (MRT) of the thyroid, existing SPECT systems are unable to accurately quantify the radiation absorbed by those patients undergoing treatment. As a consequence, only limited information regarding the success of this radiotherapy treatment has been available — that is, until now.

Wolfmet 3D printed tungsten collimator
Wolfmet 3D printed tungsten collimator

Experts from the University of Liverpool - Department of Physics, and The Royal Marsden and Royal Liverpool University Hospitals have been working to develop an imaging system (known as DEPICT) that will better quantify the absorbed radiation and help facilitate personalized treatment planning. The ability to individualize treatments is expected to reduce costs by improving efficacy and patient throughput and simultaneously increase rates of successful cancer treatment, leading to improved quality of life and health for those patients.

A critical part of the new imaging system is the CZT detector. This is used in conjunction with a parallel hole collimator with an active area comprising an array of 0.6mm Ø holes. Dismissing the use of lead for such an intricate design because of its unsuitable mechanical properties, the researchers decided that high-density tungsten was the ideal material for the collimator. However, it would have taken many weeks and tens of thousands of pounds to produce the collimator with standard machining methods. The research team realized that they had to find a more innovative solution. That solution was Wolfmet 3D.

Wolfmet 3D is the revolutionary additive manufacturing process provided by M&I Materials (a specialist materials manufacturer based in Manchester, UK). The process utilizes a high-powered laser to fuse successive layers of tungsten powder until a complex component is built. It is perfect for the manufacture of high-precision components such as collimators. Furthermore, collimators can be produced quickly and cost-effectively (in days rather than weeks). The Wolfmet team worked alongside the researchers to establish the optimal design and initial tests have shown the system to be a success.

With its excellent attenuation properties, a Wolfmet 3D tungsten collimator will significantly reduce septal penetration in comparison with the same collimator made from lead — resulting in much-improved image quality.

"The technical solution provided by M&I Materials was ideal for our application. Communication with the team was extremely valuable, and the project benefited greatly from the technical leadership that M&I Materials undertook to produce our design. The final product shows great potential to enable better radiotherapy treatment monitoring." — Dr Samantha Colosimo, University of Liverpool

The team working on the project is hopeful that the DEPICT imaging system will be available commercially in the next 3 years.

We are showcasing Wolfmet 3D products at the EANM Annual Congress 2017 in Vienna, Austria 21st-25th Oct - Hall 2 - 238.

Contact:
Miss Cooper
Phone: +44 161 864 5416
Email: marketing@mimaterials.com  

Related Images

image1.jpg

image2.jpg

Related Video

http://www.youtube.com/watch?v=SpXJtfco43g

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innovation-for-personalised-cancer-treatment-with-depict-and-wolfmet-3d-tungsten-by-mi-materials-300483525.html


'/>"/>
SOURCE M&I Materials Ltd
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Wireless Pill Bottle Wins Healthcare Innovation World Cup
2. PENTAX Medical And Hitachi-Aloka Medical Continue Joint Innovation And Global Leadership In Endoscopic Ultrasound Systems
3. Mega Trends Foster Investment, Innovation and Expansion in Latin America, Finds Frost & Sullivan
4. Craneware Showcases Pharmacy Innovation at ASHP Summer Conference
5. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
6. Olympus Showcases ENDOEYE FLEX 5 at Premiers National Healthcare Innovation Event
7. West to Celebrate 90 Years of Healthcare Innovation at the NYSE
8. CPhI Opens Awards to Global Pharma Industry, Celebrating Tomorrows Innovations Today
9. Orthocare Innovations Once Again Recognized for Top Honors for its Breakthrough Prosthetic Foot Ankle System
10. Epilepsy Foundation Launches The "Epilepsy Innovation Seal Of Excellence" Recognizing Groundbreaking Product Candidates For People With Epilepsy
11. Austen BioInnovation Institute Gains Funding from The Burton D. Morgan Foundation to Accelerate Biomedical Innovation, Train Young Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2017)... Massachusetts , July 25, 2017 The med-tech ... rare nervous system diseases, has concluded a worldwide license agreement ... drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing agreement ... a Phase 2 study conducted in Europe ... the United States ...
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. (NYSE: ... release its second quarter 2017 operating results on Monday, ... call to follow at 5:00 p.m. ET. ... listen to a live broadcast of the conference call ... referencing participant code 51641230 approximately 15 minutes prior to ...
(Date:7/21/2017)... International plc (NASDAQ: ENDP ) today announced ... network, the Company will be ceasing operations and closing ... Alabama . The closure of the facilities is ... 18 months. The Huntsville location ... and these restructuring actions are intended to better match ...
Breaking Medicine Technology:
(Date:7/24/2017)... , ... July 24, 2017 ... ... Director,      (407) 916-7235, kklaproth(at)robinsmorton(dot)com , Robins & Morton, Perkins ... to celebrate the structural topping out of the new Destination Medical Building ...
(Date:7/24/2017)... , ... July 24, 2017 , ... SignatureCare Emergency ... will be awarded for the fall semester to a deserving student. Get your ... Spring 2017 scholarship was awarded to Mariana Castillo who is a nursing student at ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... Abuse and Mental Health Services Administration’s (SAMHSA) State Targeted Response to the Opioid ... Health Care Services, will facilitate the development of a hub and spoke model ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... effectively destroyed the construction site and threatened numerous homes and businesses nearby, causing ... article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection Group, Inc. ...
(Date:7/24/2017)... ... July 24, 2017 , ... The International Essential Tremor Foundation (IETF) will ... essential tremor (ET). The seminar will take place on Saturday, Aug. 26 at the ... The program will run from 9 a.m. to 12 p.m., with check-in beginning at ...
Breaking Medicine News(10 mins):